The NEURVESTA device is currently available for research use only.
Our First Product
The NEURVESTA wearable device enables proactive screening for balance impairments and delivery of corrective therapeutic treatment to much larger numbers of older people, including those with limited healthcare access.
- NEURVESTA has been developed, tested, and validated in clinical pilots under IRB, and a standard 6-week treatment protocol has been developed, with three 15-minute sessions per week, minimizing clinical workflow impact.
- NEURVESTA balance enhancements have been shown to be cumulative and persistent across a wide age range (50-90), to increase ambulatory confidence, and to significantly reduce fall risks.
- The ease-of use and wearable form factor allow NEURVESTA treatments to be delivered by non-specialist health care practitioners in any doctor’s office, physical therapy or rehabilitation clinic, senior care location, and eventually via at-home patient care.
NEURVESTA expands access to comprehensive personalized care for tens of millions of people with balance disruptions.
NEURVESTA bridges the wide gap between demand vs. availability of vestibular specialists who can diagnose and treat balance disruptions.
NEURVESTA bridges the wide gap between demand vs. availability of clinical neurologists who can diagnose and treat balance disruptions.
NEURVESTA allows rehab providers to deliver more comprehensive personalized care for patients with balance disruptions.
NEURVESTA allows primary care providers to deliver more comprehensive personalized care for patients with balance disruptions.
NEURVESTA allows physical therapy providers to deliver more comprehensive personalized care for patients with balance disruptions.
NEURVESTA expands access to comprehensive personalized diagnoses and treatments for tens of millions of people with balance disruptions.
Contact Us
Learn more about Neursantys R&D collaborations, pilot deployments, and employment opportunities.
Contact Us
